Bidding war between Pfizer, Novo Nordisk for obesity startup Metsera escalates The higher bid, from the Danish drugmaker, would value the biotech at up to $10 billion

https://www.statnews.com/2025/11/04/pfizer-novo-nordisk-metsera-bidding-war/